MedTrace Logo

Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function

NCT03518281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-12-05

No results posted yet for this study

Summary

Upper respiratory tract infections cause cold and flu-like symptoms and are the most common form of acute illness. Certain populations are at increased risk of upper respiratory tract infections including athletes who train at a high level of intensity for prolonged periods of time. Consequently, some athletes experience higher rates of cold and flu-like symptoms than the general population.

Euglena gracilis is a micro-algae which can synthesize many nutrients necessary for human health, including insoluble beta glucan. Thus, intake of whole cell Euglena may be beneficial to athletes by providing essential vitamins to optimize immune function.

Conditions

  • Symptoms Flu
  • Symptoms Cold

Interventions

DIETARY_SUPPLEMENT

Whole Cell Euglena containing Beta Glucan

Whole Cell Euglena containing \>50% Beta Glucan

DIETARY_SUPPLEMENT

Placebo

microcrystalline cellulose, hypromellose, titanium dioxide, water

Sponsors & Collaborators

  • KGK Science Inc.

    collaborator INDUSTRY

  • Kemin Foods LC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-28
Primary Completion
2018-09-01
Completion
2018-12-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03518281 on ClinicalTrials.gov